Variant report

Variant	nsv881328
Chromosome Location	chr5:1637461-1671200
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1366)
CpG islands
(count:3425)
Chromatin interactive
region (count:38)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1366 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:1645169-1645328	HepG2	liver:	n/a	n/a
2	ARID3A	chr5:1641697-1642037	K562	blood:	n/a	n/a
3	ARID3A	chr5:1641691-1642038	HepG2	liver:	n/a	n/a
4	ARID3A	chr5:1645263-1645298	K562	blood:	n/a	n/a
5	ATF1	chr5:1641716-1642049	K562	blood:	n/a	n/a
6	ATF3	chr5:1667407-1667617	K562	blood:	n/a	n/a
7	ATF3	chr5:1641603-1642017	A549	lung:	n/a	n/a
8	BACH1	chr5:1644979-1645538	H1-hESC	embryonic stem cell:	n/a	n/a
9	BACH1	chr5:1667412-1668640	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr5:1641571-1642072	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr5:1641816-1642005	K562	blood:	n/a	n/a
12	BATF	chr5:1653605-1654275	GM12878	blood:	n/a	n/a
13	BATF	chr5:1641688-1641949	GM12878	blood:	n/a	n/a
14	BCL11A	chr5:1653619-1654286	GM12878	blood:	n/a	chr5:1653982-1653995 chr5:1654156-1654165
15	BCL11A	chr5:1644533-1645035	GM12878	blood:	n/a	n/a
16	BCL11A	chr5:1653936-1654251	GM12878	blood:	n/a	chr5:1653982-1653995 chr5:1654156-1654165
17	BCLAF1	chr5:1641629-1642022	GM12878	blood:	n/a	n/a
18	BHLHE40	chr5:1641749-1642002	HepG2	liver:	n/a	n/a
19	BHLHE40	chr5:1641683-1641979	K562	blood:	n/a	n/a
20	BHLHE40	chr5:1670575-1670743	K562	blood:	n/a	n/a
21	BHLHE40	chr5:1653721-1653915	HepG2	liver:	n/a	n/a
22	BHLHE40	chr5:1641726-1642051	GM12878	blood:	n/a	n/a
23	BHLHE40	chr5:1645063-1645300	K562	blood:	n/a	n/a
24	BHLHE40	chr5:1653572-1653949	GM12878	blood:	n/a	n/a
25	BRCA1	chr5:1645095-1645344	H1-hESC	embryonic stem cell:	n/a	n/a
26	BRCA1	chr5:1645082-1645320	Hela-S3	cervix:	n/a	n/a
27	BRCA1	chr5:1641697-1642053	Hela-S3	cervix:	n/a	n/a
28	CBX3	chr5:1641702-1642008	K562	blood:	n/a	n/a
29	CBX3	chr5:1644959-1645380	K562	blood:	n/a	n/a
30	CBX3	chr5:1641624-1642028	K562	blood:	n/a	n/a
31	CEBPB	chr5:1670477-1670802	IMR90	lung:	n/a	n/a
32	CEBPB	chr5:1645064-1645330	H1-hESC	embryonic stem cell:	n/a	n/a
33	CEBPB	chr5:1641776-1641937	K562	blood:	n/a	n/a
34	CEBPB	chr5:1670375-1670874	Hela-S3	cervix:	n/a	chr5:1670812-1670825
35	CEBPB	chr5:1670504-1670660	A549	lung:	n/a	n/a
36	CEBPB	chr5:1667446-1667643	H1-hESC	embryonic stem cell:	n/a	n/a
37	CEBPB	chr5:1641718-1642048	Hela-S3	cervix:	n/a	n/a
38	CEBPB	chr5:1645053-1645315	Hela-S3	cervix:	n/a	n/a
39	CHD1	chr5:1644949-1645493	IMR90	lung:	n/a	n/a
40	CHD2	chr5:1645113-1645239	HepG2	liver:	n/a	n/a
41	CHD2	chr5:1641723-1642008	Hela-S3	cervix:	n/a	n/a
42	CHD2	chr5:1652280-1652291	Hela-S3	cervix:	n/a	n/a
43	CHD2	chr5:1645113-1645215	K562	blood:	n/a	n/a
44	CHD2	chr5:1668625-1668631	K562	blood:	n/a	n/a
45	CHD2	chr5:1667458-1667528	K562	blood:	n/a	n/a
46	CHD2	chr5:1667485-1667534	H1-hESC	embryonic stem cell:	n/a	n/a
47	CHD2	chr5:1641835-1641964	K562	blood:	n/a	n/a
48	CHD2	chr5:1645051-1645407	H1-hESC	embryonic stem cell:	n/a	n/a
49	CHD2	chr5:1645028-1645246	Hela-S3	cervix:	n/a	n/a
50	CREB1	chr5:1645071-1645361	A549	lung:	n/a	n/a

(count:3425 , 50 per page) page: 1 2 3 4 5 6 7 ... 69

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:1641392-1641442	Caco-2	colon:	n/a
2	chr5:1650911-1650961	BJ	skin:	n/a
3	chr5:1641001-1641051	MCF-7	breast:	n/a
4	chr5:1641392-1641442	HCPEpiC	choroid plexus:	n/a
5	chr5:1653258-1653308	SK-N-SH_RA	brain:	n/a
6	chr5:1648083-1648133	HEK293	kidney:	embryo
7	chr5:1644542-1644592	SK-N-MC	brain:	n/a
8	chr5:1667643-1667693	HL-60	blood:	n/a
9	chr5:1653609-1653659	SK-N-SH_RA	brain:	n/a
10	chr5:1641392-1641442	Caco-2	colon:	n/a
11	chr5:1650911-1650961	BJ	skin:	n/a
12	chr5:1641001-1641051	MCF-7	breast:	n/a
13	chr5:1641392-1641442	HCPEpiC	choroid plexus:	n/a
14	chr5:1653258-1653308	SK-N-SH_RA	brain:	n/a
15	chr5:1648083-1648133	HEK293	kidney:	embryo
16	chr5:1644542-1644592	SK-N-MC	brain:	n/a
17	chr5:1667643-1667693	HL-60	blood:	n/a
18	chr5:1653609-1653659	SK-N-SH_RA	brain:	n/a
19	chr5:1645577-1645627	AG09319	gingival:	n/a
20	chr5:1667643-1667693	U87	brain:	n/a
21	chr5:1643655-1643705	NH-A	brain:	n/a
22	chr5:1666551-1666601	HRCEpiC	kidney:	n/a
23	chr5:1641647-1641697	AoSMC	blood vessel:	n/a
24	chr5:1667958-1668008	K562	blood:	n/a
25	chr5:1653609-1653659	GM12891	blood:	n/a
26	chr5:1641876-1641926	HPAEpiC	pulmonary alveolar:	n/a
27	chr5:1666974-1667024	MCF-7	breast:	n/a
28	chr5:1667958-1668008	AG04450	lung:	fetal
29	chr5:1641001-1641051	H1-hESC	embryonic stem cell:	embryo
30	chr5:1660205-1660255	RPTEC	kidney:	n/a
31	chr5:1667128-1667178	MCF10A-Er-Src	breast:	n/a
32	chr5:1644520-1644570	GM06990	blood:	n/a
33	chr5:1640522-1640572	HNPCEpiC	eye:	n/a
34	chr5:1640522-1640572	SK-N-MC	brain:	n/a
35	chr5:1667958-1668008	GM12878	blood:	n/a
36	chr5:1641001-1641051	GM06990	blood:	n/a
37	chr5:1645577-1645627	BE2_C	brain:	n/a
38	chr5:1664252-1664302	HepG2	liver:	n/a
39	chr5:1645268-1645318	Jurkat	blood:	n/a
40	chr5:1660156-1660206	Hepatocyte	liver:	n/a
41	chr5:1663986-1664036	MCF-7	breast:	n/a
42	chr5:1641826-1641876	PrEC	prostate:	n/a
43	chr5:1654343-1654393	GM12891	blood:	n/a
44	chr5:1640042-1640092	GM12892	blood:	n/a
45	chr5:1648083-1648133	BE2_C	brain:	n/a
46	chr5:1666974-1667024	Caco-2	colon:	n/a
47	chr5:1644520-1644570	SAEC	small airway:	n/a
48	chr5:1644542-1644592	LNCaP	prostate:	n/a
49	chr5:1641766-1641816	GM19239	blood:	n/a
50	chr5:1667258-1667308	BE2_C	brain:	n/a

(count:38 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:1667067..1667875-chr5:1737581..1738505,2	MCF-7	breast:
2	chr5:1667410..1667946-chr5:1763618..1764383,2	MCF-7	breast:
3	chr5:1479600..1480449-chr5:1641359..1642320,8	K562	blood:
4	chr5:1601386..1602232-chr5:1644668..1645654,3	MCF-7	breast:
5	chr5:1667086..1668362-chr5:2038669..2039410,3	MCF-7	breast:
6	chr5:1479406..1480370-chr5:1644706..1645695,7	K562	blood:
7	chr5:1668302..1672131-chr5:1798623..1801644,4	MCF-7	breast:
8	chr5:1651364..1654972-chr5:1656341..1659968,4	K562	blood:
9	chr5:1632420..1636449-chr5:1636560..1641821,6	MCF-7	breast:
10	chr5:1634031..1636577-chr5:1639531..1641911,4	MCF-7	breast:
11	chr5:1667066..1668003-chr5:1750732..1751621,2	MCF-7	breast:
12	chr5:1652097..1654972-chr5:1657057..1658557,2	K562	blood:
13	chr5:1168197..1168876-chr5:1641446..1642294,3	MCF-7	breast:
14	chr5:1559974..1562443-chr5:1642820..1645262,2	K562	blood:
15	chr5:1601351..1602385-chr5:1641606..1642321,3	MCF-7	breast:
16	chr5:1670677..1673436-chr5:1679771..1681932,2	K562	blood:
17	chr5:1474066..1474782-chr5:1641613..1642314,2	MCF-7	breast:
18	chr5:1167994..1168516-chr5:1644707..1645648,2	MCF-7	breast:
19	chr5:1380531..1381134-chr5:1641418..1642008,2	K562	blood:
20	chr5:1209132..1210132-chr5:1641419..1642353,2	K562	blood:
21	chr5:1648921..1651237-chr5:1656586..1659159,2	MCF-7	breast:
22	chr5:1667119..1667843-chr5:1772505..1773334,2	MCF-7	breast:
23	chr5:1632750..1636103-chr5:1636749..1640092,3	K562	blood:
24	chr5:1665325..1667102-chr5:1669909..1672808,2	K562	blood:
25	chr5:1380129..1381053-chr5:1644702..1645623,2	K562	blood:
26	chr5:1637235..1639210-chr5:1639365..1642347,2	K562	blood:
27	chr5:1594724..1595423-chr5:1641483..1642314,2	K562	blood:
28	chr5:1667058..1667975-chr5:2038421..2039188,3	K562	blood:
29	chr5:1648921..1651237-chr5:1656586..1659159,2	MCF-7	breast:
30	chr5:1651364..1654972-chr5:1656341..1659968,4	K562	blood:
31	chr5:1208740..1209449-chr5:1644991..1645637,2	MCF-7	breast:
32	chr5:1665325..1667102-chr5:1669909..1672808,2	K562	blood:
33	chr5:1667002..1669598-chr5:1799567..1801652,2	K562	blood:
34	chr5:1669626..1671226-chr5:1885591..1887218,2	MCF-7	breast:
35	chr5:1475367..1477969-chr5:1638035..1640520,2	MCF-7	breast:
36	chr5:1637235..1639210-chr5:1639365..1642347,2	K562	blood:
37	chr5:1652097..1654972-chr5:1657057..1658557,2	K562	blood:
38	chr12:52596128..52598397-chr5:1635134..1637588,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000188002	TF binding region
ENSG00000188002	CpG island
ENSG00000145494	chromatin interactions
ENSG00000188002	chromatin interactions
ENSG00000271119	chromatin interactions
ENSG00000171421	chromatin interactions
ENSG00000185986	chromatin interactions
ENSG00000250584	chromatin interactions

Extended variants
information (count: 1643 )
Associated
traits (count: 115 )

Variant overlapped rSNPs/rCNVs (count:1643 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10052477	chr5:1637461-1637462	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs531874512	chr5:1637470-1637471	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs550189320	chr5:1637498-1637499	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs9312910	chr5:1637502-1637503	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs374704683	chr5:1637509-1637510	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs551345611	chr5:1637513-1637514	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs369053687	chr5:1637519-1637520	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs533713277	chr5:1637520-1637521	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs532901898	chr5:1637558-1637559	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs13158448	chr5:1637565-1637566	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs572435724	chr5:1637566-1637567	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs139466453	chr5:1637584-1637585	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs74815452	chr5:1637603-1637604	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs534303542	chr5:1637631-1637632	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs59875755	chr5:1637646-1637647	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs556224704	chr5:1637682-1637683	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs149986148	chr5:1637706-1637707	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs115845315	chr5:1637733-1637734	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs73037894	chr5:1637781-1637782	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs572727105	chr5:1637794-1637795	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs58452381	chr5:1637795-1637796	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs185855430	chr5:1637800-1637801	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs531650580	chr5:1637859-1637860	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs10475075	chr5:1637864-1637865	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs543892071	chr5:1637867-1637868	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs538224000	chr5:1637871-1637872	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs373539354	chr5:1637872-1637873	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs190260422	chr5:1637896-1637897	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs199684981	chr5:1637957-1637958	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs547795284	chr5:1637968-1637969	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs560169313	chr5:1638016-1638017	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs115763444	chr5:1638026-1638027	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs73037895	chr5:1638040-1638041	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs73037896	chr5:1638053-1638054	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs202139250	chr5:1638054-1638055	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs142367568	chr5:1638177-1638178	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs186189619	chr5:1638198-1638199	Enhancers Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs113633750	chr5:1638209-1638210	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs111847448	chr5:1638216-1638217	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs549573872	chr5:1638232-1638233	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs111653741	chr5:1638236-1638237	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs571338787	chr5:1638253-1638254	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs538233750	chr5:1638266-1638267	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs113665528	chr5:1638326-1638327	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs190664074	chr5:1638358-1638359	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs572766416	chr5:1638376-1638377	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs151296994	chr5:1638388-1638389	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs200153769	chr5:1638397-1638398	Weak transcription Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs35373789	chr5:1638405-1638406	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs113688185	chr5:1638430-1638431	Weak transcription Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:115)

Disease	PMID	Source
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16608533	CNVD
Cervical cancer	16585170	CNVD
Glioblastoma multiforme	22286061	CNVD
Lung cancer	17925434	CNVD
Ovarian cancer	20844748	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Non-small cell lung cancer	21829676	CNVD
Intracranial ependymoma	16609018	CNVD
Breast cancer	19181860	CNVD
prenatal diagnosis	20453657	CNVD
Developmental delay	19490664	CNVD
Human papillomavirus	17975027	CNVD
Acute monocytic leukemia	16498392	CNVD
Gastric cancer	16891809	CNVD
Intracranial aneurysm	16715129	CNVD
Emphysema	19352772	CNVD
Chordoma	18071362	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Lung cancer	21911935	CNVD
Cri-du chat syndrome	21549014	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Sudden cardiac death	19188705	CNVD
renal disease	17924346	CNVD
abnormal development	18461090	CNVD
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21509527	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Oral cancer	22144094	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	17550852	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Developmental delay	21147756	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
XY gonadal dysgenesis	20685758	CNVD
lymphocytic leukemia	21291569	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Breast cancer	22522925	CNVD
Intellectual disability	21811512	CNVD
Lung adenocarcinoma	21935476	CNVD

Chromatin state (count:853 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:1634600-1645000	Weak transcription	Right Atrium	heart
2	chr5:1634600-1645200	Weak transcription	Gastric	stomach
3	chr5:1635200-1640000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
4	chr5:1635400-1638000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr5:1637200-1638200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr5:1637400-1638000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
7	chr5:1637800-1638400	Bivalent Enhancer	HepG2	liver
8	chr5:1638000-1638200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr5:1638200-1638600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr5:1638400-1638600	Bivalent/Poised TSS	HepG2	liver
11	chr5:1638600-1638800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr5:1638600-1638800	Flanking Bivalent TSS/Enh	HepG2	liver
13	chr5:1638800-1639200	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr5:1638800-1639200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr5:1638800-1639400	Bivalent/Poised TSS	HepG2	liver
16	chr5:1639200-1640400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr5:1640000-1640800	Bivalent Enhancer	Fetal Muscle Leg	muscle
18	chr5:1640000-1641400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
19	chr5:1640000-1642400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr5:1640000-1642800	Enhancers	H1 Cell Line	embryonic stem cell
21	chr5:1640400-1640800	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr5:1640400-1642400	Enhancers	HUES48 Cell Line	embryonic stem cell
23	chr5:1640400-1643000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr5:1640600-1641400	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr5:1641200-1641400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
26	chr5:1641200-1641600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
27	chr5:1641200-1641800	Enhancers	Cortex derived primary cultured neurospheres	brain
28	chr5:1641200-1642200	Enhancers	Breast Myoepithelial Primary Cells	Breast
29	chr5:1641400-1641600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
30	chr5:1641400-1641600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
31	chr5:1641400-1641600	Enhancers	H9 Cell Line	embryonic stem cell
32	chr5:1641400-1641600	Enhancers	HUES6 Cell Line	embryonic stem cell
33	chr5:1641400-1641600	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr5:1641400-1641600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
35	chr5:1641400-1641600	Bivalent Enhancer	HepG2	liver
36	chr5:1641400-1641600	Bivalent Enhancer	NH-A	brain
37	chr5:1641400-1641800	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
38	chr5:1641400-1641800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr5:1641400-1641800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
40	chr5:1641400-1641800	Bivalent Enhancer	Osteobl	bone
41	chr5:1641400-1642200	Enhancers	iPS-18 Cell Line	embryonic stem cell
42	chr5:1641400-1642200	Enhancers	Primary T helper naive cells from peripheral blood	blood
43	chr5:1641400-1642200	Enhancers	Fetal Heart	heart
44	chr5:1641400-1643000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
45	chr5:1641600-1641800	Flanking Active TSS	ES-WA7 Cell Line	embryonic stem cell
46	chr5:1641600-1641800	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
47	chr5:1641600-1641800	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr5:1641600-1641800	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr5:1641600-1641800	Enhancers	Primary B cells from peripheral blood	blood
50	chr5:1641600-1641800	Enhancers	Primary T helper cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links